文献
J-GLOBAL ID:201102242830686928
整理番号:11A1462047
セカンドライン化学療法としてのベバシズマブによるFOLFIRIを受けている進行結腸直腸癌患者におけるイリノテカンの血漿濃度およびその代謝物に対するベバシズマブの効果
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
著者 (8件):
HORITA Yosuke
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
YAMADA Y.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
HIRASHIMA Y.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
HIRASHIMA Y.
(Oita Univ., Div. of Clinical Oncology, Fac. of Medicine, Oita, JPN)
,
KATO K.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
NAKAJIMA T.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
HAMAGUCHI T.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
,
SHIMADA Y.
(National Cancer Center Hospital, Div. of Gastrointestinal Oncology, Tsukiji 5-1-1, Chuo-ku, 104-0045, Tokyo, JPN)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
65
号:
3
ページ:
467-471
発行年:
2010年02月
JST資料番号:
D0065D
ISSN:
0344-5704
CODEN:
CCPHDZ
資料種別:
逐次刊行物 (A)
発行国:
ドイツ (DEU)
言語:
英語 (EN)